← Back
Data updated: Mar 10, 2026
P AND L
Infectious DiseaseCardiovascularGastroenterology
P AND L is a generic drug manufacturer focused on Infectious Disease, Cardiovascular, Gastroenterology. Key products include ESOMEPRAZOLE MAGNESIUM.
1993
Since
17
Drugs
-
Trials
127
Approved (2yr)
Recent Activity
NICOTINE POLACRILEX 2026-02-05
Labeling
DOCOSANOL 2025-10-23
DOCOSANOL 2025-10-03
OMEPRAZOLE MAGNESIUM 2025-08-07
FAMOTIDINE 2025-07-24
NICOTINE POLACRILEX 2025-07-17
FAMOTIDINE 2025-07-16
Type 5 - New Formulation or New Manufacturer
FAMOTIDINE 2025-07-09
MINOXIDIL EXTRA STRENGTH (FOR MEN) 2025-06-30
FAMOTIDINE 2025-06-23
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 33%
1 drugs
Cardiovascular 33%
1 drugs
Gastroenterology 33%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology
Pfizer big-pharma
Infectious Disease, Gastroenterology
WAYLIS THERAP big-pharma
Cardiovascular, Infectious Disease, Gastroenterology
Merck big-pharma
Infectious Disease, Cardiovascular
WARNER CHILCOTT LLC specialty
Cardiovascular, Gastroenterology, Infectious Disease
Active (12)
Discontinued (5)
Company Info
- First Approval
- 1993-07-16
- Latest
- 2026-02-05
- Applications
- 35